Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Crispr Therapeutics Ag Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$100 Billion
Q4 2024

A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 5,252 shares of CRSP stock, worth $264,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,252

Previous 4,880 7.62%

Holding current value

$264,858

Previous $229,000 10.04%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$38.65 - $55.15 $14,377 - $20,515	372 Added 7.62%	5,252 $206,000
Q3 2024 Nov 07, 2024	SELL	$44.62 - $62.75 $20,257 - $28,488	-454 Reduced 8.51%	4,880 $229,000
Q2 2024 Aug 12, 2024	BUY	$51.17 - $68.18 $102,442 - $136,496	2,002 Added 60.08%	5,334 $288,000
Q1 2024 May 09, 2024	SELL	$60.67 - $89.12 $9,039 - $13,278	-149 Reduced 4.28%	3,332 $227,000
Q4 2023 Feb 08, 2024	SELL	$38.62 - $72.18 $38,735 - $72,396	-1,003 Reduced 22.37%	3,481 $217,000
Q3 2023 Nov 07, 2023	BUY	$45.39 - $59.0 $3,449 - $4,484	76 Added 1.72%	4,484 $203,000
Q2 2023 Aug 09, 2023	SELL	$43.47 - $67.77 $11,823 - $18,433	-272 Reduced 5.81%	4,408 $247,000
Q1 2023 May 08, 2023	BUY	$41.0 - $56.12 $13,407 - $18,351	327 Added 7.51%	4,680 $211,000
Q4 2022 Feb 07, 2023	SELL	$39.19 - $65.67 $4,350 - $7,289	-111 Reduced 2.49%	4,353 $176,000
Q3 2022 Nov 01, 2022	BUY	$61.1 - $83.78 $5,376 - $7,372	88 Added 2.01%	4,464 $292,000
Q2 2022 Aug 04, 2022	BUY	$43.23 - $73.83 $26,327 - $44,962	609 Added 16.17%	4,376 $266,000
Q1 2022 May 09, 2022	BUY	$53.19 - $79.24 $15,957 - $23,772	300 Added 8.65%	3,767 $236,000
Q4 2021 Feb 07, 2022	BUY	$70.09 - $111.29 $46,820 - $74,341	668 Added 23.87%	3,467 $275,000
Q2 2021 Aug 06, 2021	SELL	$100.84 - $161.89 $49,915 - $80,135	-495 Reduced 15.03%	2,799 $453,000
Q1 2021 May 06, 2021	BUY	$110.72 - $210.04 $114,927 - $218,021	1,038 Added 46.01%	3,294 $401,000
Q4 2020 Feb 09, 2021	SELL	$79.67 - $173.23 $58,079 - $126,284	-729 Reduced 24.42%	2,256 $345,000
Q3 2020 Nov 10, 2020	SELL	$78.5 - $100.64 $1,099 - $1,408	-14 Reduced 0.47%	2,985 $250,000
Q2 2020 Aug 06, 2020	BUY	$38.5 - $76.05 $14,976 - $29,583	389 Added 14.9%	2,999 $220,000
Q1 2020 May 11, 2020	BUY	$33.68 - $62.53 $20,106 - $37,330	597 Added 29.66%	2,610 $111,000
Q4 2019 Feb 05, 2020	SELL	$36.68 - $73.13 $60,228 - $120,079	-1,642 Reduced 44.92%	2,013 $120,000
Q3 2019 Nov 12, 2019	BUY	$40.99 - $52.56 $24,389 - $31,273	595 Added 19.44%	3,655 $150,000
Q2 2019 Aug 08, 2019	SELL	$35.45 - $48.2 $41,122 - $55,912	-1,160 Reduced 27.49%	3,060 $144,000
Q1 2019 Apr 26, 2019	BUY	$28.02 - $40.87 $6,528 - $9,522	233 Added 5.84%	4,220 $151,000
Q4 2018 Feb 08, 2019	BUY	$22.73 - $42.34 $40,118 - $74,730	1,765 Added 79.43%	3,987 $112,000
Q3 2018 Nov 13, 2018	BUY	$44.35 - $65.71 $98,545 - $146,007	2,222 New	2,222 $99,000

Others Institutions Holding CRSP

# of Institutions

484

Shares Held

64.1M

Call Options Held

1.64M

Put Options Held

1.93M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.93B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account

Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Crispr Therapeutics Ag Transaction History